Chang, Andrew A <br/><br/>
Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes.  [electronic resource] 

 -  Ophthalmic research  2015 
 - 84-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0259 
<br/><br/><label>Standard No.: </label>10.1159/000440886  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--adverse effects<br/>Choroidal Neovascularization--diagnosis<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Prospective Studies<br/>Receptors, Vascular Endothelial Growth Factor--adverse effects<br/>Recombinant Fusion Proteins--adverse effects<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology<br/>Wet Macular Degeneration--diagnosis